SE447249B - Bensamidinderivat jemte terapeutisk komposition innefattande derivatet - Google Patents

Bensamidinderivat jemte terapeutisk komposition innefattande derivatet

Info

Publication number
SE447249B
SE447249B SE7807881A SE7807881A SE447249B SE 447249 B SE447249 B SE 447249B SE 7807881 A SE7807881 A SE 7807881A SE 7807881 A SE7807881 A SE 7807881A SE 447249 B SE447249 B SE 447249B
Authority
SE
Sweden
Prior art keywords
formula
pharmaceutically acceptable
group
derivative
benzamidine
Prior art date
Application number
SE7807881A
Other languages
English (en)
Swedish (sv)
Other versions
SE7807881L (sv
Inventor
M Noel
Original Assignee
Aron Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aron Sa filed Critical Aron Sa
Publication of SE7807881L publication Critical patent/SE7807881L/xx
Publication of SE447249B publication Critical patent/SE447249B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • C07D271/07—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38—Nitrogen atoms
    • C07D231/40—Acylated on said nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/14—Nitrogen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE7807881A 1977-07-20 1978-07-17 Bensamidinderivat jemte terapeutisk komposition innefattande derivatet SE447249B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB30523/77A GB1587945A (en) 1977-07-20 1977-07-20 Benzamidine derivatives

Publications (2)

Publication Number Publication Date
SE7807881L SE7807881L (sv) 1979-01-21
SE447249B true SE447249B (sv) 1986-11-03

Family

ID=10309001

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7807881A SE447249B (sv) 1977-07-20 1978-07-17 Bensamidinderivat jemte terapeutisk komposition innefattande derivatet

Country Status (16)

Country Link
US (1) US4246272A (fr)
JP (1) JPS5452077A (fr)
AT (1) AT359491B (fr)
AU (1) AU516005B2 (fr)
BE (1) BE868659A (fr)
CA (1) CA1095055A (fr)
CH (1) CH633000A5 (fr)
DE (1) DE2831457A1 (fr)
ES (2) ES471895A1 (fr)
FR (1) FR2398066A1 (fr)
GB (1) GB1587945A (fr)
IL (1) IL55088A (fr)
IT (1) IT1107844B (fr)
NL (1) NL7807679A (fr)
SE (1) SE447249B (fr)
ZA (1) ZA783830B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4416683A (en) * 1980-09-16 1983-11-22 Eli Lilly And Company Benzamides, compositions and agricultural method
US5086184A (en) * 1980-09-16 1992-02-04 Dowelanco N-heterocyclic benzamides
US4636243A (en) * 1980-09-16 1987-01-13 Eli Lilly And Company Benzamides, compositions and agricultural method
US4943634A (en) * 1980-09-16 1990-07-24 Eli Lilly And Company N-heterocyclic benzamides
IL165365A0 (en) 2004-11-24 2006-01-15 Q Core Ltd Finger-type peristaltic pump

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1668851B2 (de) * 1963-03-22 1973-05-03 Amidine und verfahren zu ihrer herstellung
GB1267009A (fr) * 1969-07-25 1972-03-15
CA1039308A (fr) * 1974-10-02 1978-09-26 James R. Mccarthy (Jr.) Halophenylacetamidines et benzamidines substituees en n,n'

Also Published As

Publication number Publication date
ATA497478A (de) 1980-04-15
JPS6223751B2 (fr) 1987-05-25
ZA783830B (en) 1979-07-25
SE7807881L (sv) 1979-01-21
IL55088A0 (en) 1978-09-29
AU516005B2 (en) 1981-05-14
IL55088A (en) 1981-07-31
AT359491B (de) 1980-11-10
FR2398066B1 (fr) 1980-09-26
DE2831457A1 (de) 1979-02-01
US4246272A (en) 1981-01-20
BE868659A (fr) 1979-01-02
AU3808878A (en) 1980-01-17
GB1587945A (en) 1981-04-15
ES479110A1 (es) 1979-07-01
ES471895A1 (es) 1979-10-01
IT7868716A0 (it) 1978-07-19
DE2831457C2 (fr) 1988-07-14
JPS5452077A (en) 1979-04-24
IT1107844B (it) 1985-12-02
CH633000A5 (fr) 1982-11-15
CA1095055A (fr) 1981-02-03
FR2398066A1 (fr) 1979-02-16
NL7807679A (nl) 1979-01-23

Similar Documents

Publication Publication Date Title
RU2261860C2 (ru) ЗАМЕЩЕННЫЕ В ПОЛОЖЕНИИ 8А ПРОИЗВОДНЫЕ 8,8А-ДИГИДРОИНДЕНО [1,2-d] ТИАЗОЛА, СПОСОБ ИХ ПОЛУЧЕНИЯ И ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ ЛЕКАРСТВЕННЫХ СРЕДСТВ, НАПРИМЕР В КАЧЕСТВЕ АНОРЕКСИЧЕСКИХ СРЕДСТВ
RU2263113C2 (ru) Производные 8,8а-дигидроиндено [1,2-d]тиазола, содержащие в положении 2 заместитель с сульфонамидной или сульфоновой структурой, способ их получения и их применение в качестве лекарственного средства
CS274405B2 (en) Method of 4-cyanopyridazines preparation
KR900004126B1 (ko) 아릴피페라지닐-에틸(또는 부틸)-페닐-헤테로시클릭 화합물
US4018830A (en) Phenylthioaralkylamines
JPH0455436B2 (fr)
SE447249B (sv) Bensamidinderivat jemte terapeutisk komposition innefattande derivatet
US7741342B2 (en) Water-soluble thalidomine derivatives
EP2870141B1 (fr) Composés méthanethiones ayant une activité antivirale
KR20020002394A (ko) 비만증 예방 또는 치료용 약제를 제조하기 위한,폴리사이클릭 2-아미노-티아졸계의 용도
AU602053B2 (en) 5-(3-alkyl-5-tert. butyl-4-hydroxyphenyl)-2-amino-6h-1,3,4- thia-diazines, a process for the preparation thereof, medicaments containing same, and the use thereof
JPH0667919B2 (ja) 新規なインデノチアゾ−ル誘導体及びその製造法
WO2014104272A1 (fr) Dérivé d'amide d'acide cinnamique
JPH11209284A (ja) 骨形成促進剤
JPH11509520A (ja) 鎮痛特性を有する新規のｎ−アセチル化４−ヒドロキシフェニルアミン誘導体及びそれを含む薬理組成物
US3597429A (en) Derivatives of tetrazolyl alkanoic acids
US3704240A (en) 3-substituted-4-hydroxy - 2 - substituted imino - 4 - phenyl-5-thiazolidine alkyl carboxylic acids and their alkyl esters
KR830002478B1 (ko) 구아니디노 티아졸 화합물의 제조방법
JPS6035344B2 (ja) チアゾリジン誘導体の製造方法
DK143104B (da) Analogifremgangsmaade til fremstilling af anilinophenylacetamidderivater eller salte deraf
RU2263669C2 (ru) Замещенные 8,8a-дигидро-3ah-индено [1,2-d] тиазолы, способ их получения и их применение в качестве лекарственных средств
JPS61115074A (ja) ３，４‐ジアゾール誘導体、その製法、およびその化合物を含有する医薬品
CZ2004124A3 (cs) Název neuveden
JP2596829B2 (ja) ピリミドン誘導体の製造方法
JPS63130570A (ja) ３，５−ジ第３級ブチル−４−ヒドロキシ桂皮酸アミド誘導体

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7807881-3

Effective date: 19920210

Format of ref document f/p: F